These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35347801)

  • 41. RADIATION THERAPY COMMUNICATION-REIRRADIATION OF A NASAL TUMOR IN A BRACHYCEPHALIC DOG USING INTENSITY MODULATED RADIATION THERAPY.
    Rancilio NJ; Custead MR; Poulson JM
    Vet Radiol Ultrasound; 2016 Sep; 57(5):E46-50. PubMed ID: 26729295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of simultaneous radiation boost achieves high treatment response rate in patients with metastatic gastric cancer.
    Yang J; Liu J; Gao S; Yang Y; Kong W; Ren W; Zhu L; Yang M; Wei J; Zou Z; Qian X; Liu B; Yan J
    J Cancer Res Ther; 2018 Jan; 14(1):36-39. PubMed ID: 29516956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of two dose calculation algorithms-anisotropic analytical algorithm and Acuros XB-for radiation therapy planning of canine intranasal tumors.
    Nagata K; Pethel TD
    Vet Radiol Ultrasound; 2017 Jul; 58(4):479-485. PubMed ID: 28464564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study.
    Franco P; De Bari B; Arcadipane F; Lepinoy A; Ceccarelli M; Furfaro G; Mistrangelo M; Cassoni P; Valgiusti M; Passardi A; Casadei Gardini A; Trino E; Martini S; Iorio GC; Evangelista A; Ricardi U; Créhange G
    Radiat Oncol; 2018 Sep; 13(1):172. PubMed ID: 30201015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events.
    Songthong AP; Kannarunimit D; Chakkabat C; Lertbutsayanukul C
    Radiat Oncol; 2015 Aug; 10():166. PubMed ID: 26253488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nasal angiofibroma treatment outcome using intensity-modulated radiation therapy in a dog.
    L Ashworth H; K Flesner B; J Norquest C; A Maitz C
    Vet Radiol Ultrasound; 2021 Jul; 62(4):e40-e43. PubMed ID: 33634903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome and toxicity of intensity-modulated radiotherapy with simultaneous integrated boost in patients with pharyngo-laryngeal cancer.
    Fondevilla Soler A; López-Guerra JL; García Fernández A; Samaniego Conde MA; Belmonte González MJ; Praena-Fernandez JM; Rivin Del Campo E; Alcaraz M; Azinovic I
    Clin Transl Oncol; 2019 Jul; 21(7):881-890. PubMed ID: 30506131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reirradiation of recurrent canine nasal tumors.
    Bommarito DA; Kent MS; Selting KA; Henry CJ; Lattimer JC
    Vet Radiol Ultrasound; 2011; 52(2):207-12. PubMed ID: 21388476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
    Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
    Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
    Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiation therapy for incompletely resected canine mast cell tumors.
    LaDue T; Price GS; Dodge R; Page RL; Thrall DE
    Vet Radiol Ultrasound; 1998; 39(1):57-62. PubMed ID: 9491519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma.
    Fakhrian K; Oechsner M; Kampfer S; Schuster T; Molls M; Geinitz H
    Strahlenther Onkol; 2013 Apr; 189(4):293-300. PubMed ID: 23443611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy.
    Dolezel M; Odrazka K; Vaculikova M; Vanasek J; Sefrova J; Paluska P; Zouhar M; Jansa J; Macingova Z; Jarosova L; Brodak M; Moravek P; Hartmann I
    Strahlenther Onkol; 2010 Apr; 186(4):197-202. PubMed ID: 20354663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DOSIMETRIC CONSEQUENCES OF USING CONTRAST-ENHANCED COMPUTED TOMOGRAPHIC IMAGES FOR INTENSITY-MODULATED STEREOTACTIC BODY RADIOTHERAPY PLANNING.
    Yoshikawa H; Roback DM; Larue SM; Nolan MW
    Vet Radiol Ultrasound; 2015; 56(6):687-95. PubMed ID: 26242716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IMRT for sinonasal tumors minimizes severe late ocular toxicity and preserves disease control and survival.
    Duprez F; Madani I; Morbée L; Bonte K; Deron P; Domján V; Boterberg T; De Gersem W; De Neve W
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):252-9. PubMed ID: 22027259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comorbidities and intensity-modulated radiotherapy with simultaneous integrated boost in elderly breast cancer patients.
    Fiorentino A; Mazzola R; Giaj Levra N; Fersino S; Ricchetti F; Di Paola G; Gori S; Massocco A; Alongi F
    Aging Clin Exp Res; 2018 May; 30(5):533-538. PubMed ID: 28755327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response rate and duration associated with a 4Gy 5 fraction palliative radiation protocol.
    McDonald C; Looper J; Greene S
    Vet Radiol Ultrasound; 2012; 53(3):358-64. PubMed ID: 22182209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors influencing survival after radiotherapy of nasal tumors in 130 dogs.
    LaDue TA; Dodge R; Page RL; Price GS; Hauck ML; Thrall DE
    Vet Radiol Ultrasound; 1999; 40(3):312-7. PubMed ID: 10519313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Five-year survival outcomes of intensity-modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) using forward IMRT or Tomotherapy for breast cancer.
    Lee HH; Chen CH; Luo KH; Chuang HY; Huang CJ; Cheng YK; Chen F; Kuo SH; Huang MY
    Sci Rep; 2020 Mar; 10(1):4342. PubMed ID: 32152428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.